BCRX

| Held by: VTI XBI IWM VB VXF VBK IBB IWO CALF VTWO

Index	RUT	P/E	-	EPS (ttm)	-1.78	Insider Own	9.60%	Shs Outstand	254.01M	Perf Week	-12.54%
Market Cap	2.13B	Forward P/E	26.71	EPS next Y	0.31	Insider Trans	-1.92%	Shs Float	214.36M	Perf Month	-7.10%
Enterprise Value	2.75B	PEG	-	EPS next Q	0.16	Inst Own	84.53%	Short Float	17.46%	Perf Quarter	12.35%
Income	-457.98M	P/S	2.40	EPS this Y	-321.28%	Inst Trans	5.81%	Short Ratio	6.76	Perf Half Y	19.57%
Sales	885.72M	P/B	-	EPS next Y	111.70%	ROA	-96.92%	Short Interest	37.42M	Perf YTD	7.31%
Book/sh	-2.18	P/C	8.89	EPS next 5Y	-29.26%	ROE	-	52W High	11.31 -25.99%	Perf Year	-16.88%
Cash/sh	0.94	P/FCF	7.26	EPS past 3/5Y	- -	ROIC	-175.59%	52W Low	6.00 39.50%	Perf 3Y	-0.83%
Dividend Est.	-	EV/EBITDA	8.63	Sales past 3/5Y	47.82% 117.89%	Gross Margin	97.52%	Volatility	3.95% 4.97%	Perf 5Y	-39.61%
Dividend TTM	-	EV/Sales	3.10	EPS Y/Y TTM	-569.22%	Oper. Margin	35.67%	ATR (14)	0.43	Perf 10Y	152.11%
Dividend Ex-Date	-	Quick Ratio	1.88	Sales Y/Y TTM	75.92%	Profit Margin	-51.71%	RSI (14)	39.13	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	1.91	EPS Q/Q	-2979600.00%	SMA20	-6.50%	Beta	0.57	Target Price	21.30
Payout	0.00%	Debt/Eq	-	Sales Q/Q	7.48%	SMA50	-8.89%	Rel Volume	0.72	Prev Close	8.74
Employees	435	LT Debt/Eq	-	Earnings	May 06 BMO	SMA200	5.77%	Avg Volume	5.54M	Price	8.37
IPO	Mar 04, 1994	Option/Short	Yes / Yes	EPS/Sales Surpr.	-6826.86% 3.50%	Trades		Volume	4,008,368	Change	-4.23%

Biocryst Pharmaceuticals Inc

Upgrade your Finviz experience